Concepedia

Author

Roberto Bianco

University of Naples Federico IIORCID

Also Known As

Bianco, Roberto, R BIANCO, R Bianco, R P Bianco, R. Bianco, ROBERTO BIANCO, Roberto Bianco

494

Publications

12.1K

Citations

58

H-Index

111

Concepts

All Affiliations

University of Naples Federico IILuigi Sacco HospitalFederico II University HospitalIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale"University of Campania "Luigi Vanvitelli"
RB

About

Roberto Bianco is an author at University of Naples Federico II specializing in medicine, oncology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

24

39

4.6K

2

Health Sciences

11

12

258

3

Engineering

1

1

12

4

Public Health

1

1

27

5

Applied Physiology

1

1

13

Roberto Bianco

×

105

Publications

8.9K

Citations

47

H-Index

YearCitations

Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor.

Fortunato Ciardiello, R. Caputo, Roberto Bianco,

PubMed

2000

938

Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.

Fortunato Ciardiello, Rosa Caputo, Roberto Bianco,

PubMed

2001

644

Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo.

Stacy L. Moulder, F. Michael Yakes, Senthil K. Muthuswamy,

PubMed

2001

548

Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors

Roberto Bianco, Incheol Shin, Christoph A. Ritter,

Oncogene

2003

452

Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.

Fortunato Ciardiello, Roberto Bianco, V. Damiano,

PubMed

2000

380

Gemcitabine and Cisplatin Versus Mitomycin, Ifosfamide, and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Randomized Phase III Study of the Italian Lung Cancer Project

Lucio Crinò, Giorgio V. Scagliotti, Serafino Ricci,

Journal of Clinical Oncology

1999

366

Antitumor Activity of ZD6474, a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Human Cancer Cells with Acquired Resistance to Antiepidermal Growth Factor Receptor Therapy

Fortunato Ciardiello, Roberto Bianco, Roberta Caputo,

Clinical Cancer Research

2004

346

Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225.

Fortunato Ciardiello, Roberto Bianco, Vincenzo Damiano,

PubMed

1999

334

Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa).

Cataldo Bianco, Giampaolo Tortora, Roberto Bianco,

PubMed

2002

246

Role of early ultrasound in detecting inflammatory intestinal disorders and identifying their anatomical location within the bowel

F. Parente, Salvatore Greco, M. Molteni,

Alimentary Pharmacology & Therapeutics

2003

220

Page 1